Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, with chunk of their earnings hinging on exports to the country.
Launched in 2015, the AMRIT pharmacies, a flagship initiative of the Ministry of Health and Family Welfare, offer a broad selection of generic and life-saving branded drugs, implants, and surgical supplies at heavily discounted prices.
Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.
Patent expiry would mean that drugmakers will be able to launch generic versions of the blockbuster drugs, which are typically priced up to 90 percent lower than their innovator drug.
New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...
Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.
Rule part of Registered Medical Practitioner (Professional Conduct) Regulations, 2023. Opponents include Indian Medical Association, but some see it as a move in the right direction.
The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.
India in trade talks with US, UK and EU. Pharma companies say 'provision for patent holders to extend life of patent on medicine beyond 20 yrs will delay entry of generic medicine'.
Central govt had proposed to apply trade margin rationalisation (TMR) approach to regulate prices of non-scheduled drugs, which would have resulted in capping trade margins.
With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.
If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS